GlassScriptPhysician profile
George S Naseef
NPI 1053382440
$4,281.78
in general payments reported to CMS, 2019-2025
19 companies · $1,023 in 2025
The $1,023 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $431 · 2021: $319 · 2022: $260 · 2023: $478 · 2024: $1,334 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Travel and Lodging: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.00 |
| Travel and Lodging | $851.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,885.51 | 2020-2024 | Spinemap, Aero-Ll, N/A |
| Providence Medical Technology, INC. | $711.01 | 2025 | |
| Depuy Synthes Sales INC. | $286.99 | 2019-2025 | Velys |
| Cerapedics INC. | $262.23 | 2021 | |
| Happe Spine | $192.19 | 2023 | |
| Medtronic USA, INC. | $180.31 | 2019 | |
| Centinel Spine, LLC | $142.43 | 2025 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $141.94 | 2019-2020 | |
| Djo, LLC | $120.00 | 2023 | Cmf |
| Medtronic, INC. | $104.66 | 2022 | |
| Orthofix Medical, INC. | $61.47 | 2025 | Shoreline Rt |
| Nevro Corp. | $47.28 | 2024 | Senza |
| Medicrea USA, Corp. | $46.97 | 2019 | |
| Boston Scientific Corporation | $41.20 | 2019 | |
| Globus Medical, INC. | $16.04 | 2025 | Vyrsa V1 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.70 | 2019 | |
| Horizon Therapeutics Plc | $13.80 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.05 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,050.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Naseef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.